Content about Sexual health

August 12, 2010
Prolatis recalls male-enhancement product

Prolatis earlier this week announced a voluntary nationwide recall of the company’s product sold under...

SALT LAKE CITY Prolatis earlier this week announced a voluntary nationwide recall of the company’s product sold under the brand name Prolatis’ after being informed by the Food and Drug Administration that lab analysis has found their male-enhancement products to contain sulfoaildenafil, an analogue of sildenafil, an FDA-approved drug used as treatment for male erectile dysfunction.

 

That makes Prolatis’ an unapproved drug, as opposed to a dietary supplement.

 

 

June 15, 2010
One condoms arrive at Target

A new condom brand has hit store shelves at Targets nationwide....

March 14, 2010
Intimacy health heats up aisles as retail pharmacies fit consumers’ comfort level

Intimacy health continues to be a hot commodity throughout retail pharmacy, especially as retailers and...

March 8, 2010
Lake Consumer Products develops over-the-counter bacterial vaginosis treatment

Lake Consumer Products last week launched vH essentials BV treatment, a homeopathic vaginal tablet that...

JACKSON, Wis. Lake Consumer Products last week launched vH essentials BV treatment, a homeopathic vaginal tablet that provides relief from the odor, discharge and discomfort often associated with bacterial vaginosis.

According to the company, vH essentials BV treatment is the first over-the-counter BV symptom treatment product to be widely distributed through retail.

February 28, 2010
NFL coach to pitch Extenze

Can two-time Super Bowl coach Jimmy Johnson do for the supplement male enhancement category what...

MONROVIA, Calif. —Can two-time Super Bowl coach Jimmy Johnson do for the supplement male enhancement category what Bob Dole did for Viagra?

That’s exactly what Biotab Nutraceuticals and its agency InterQuantum are hoping—legitimizing a supplement category that often provides the punch line for late night comics. The company signed Johnson in January to represent its Extenze male enhancement product. Biotab plans to pitch the pitchman pretty heavily to American consumers throughout the year with an overall marketing budget of $70 million.